National Vision (EYE) CEO sells 35,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

National Vision Holdings, Inc. director and Chief Executive Officer Alexander Wilkes reported an open-market sale of 35,000 shares of common stock on March 11, 2026 at a weighted average price of $26.54 per share, in multiple trades between $26.21 and $26.91.

The transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on December 5, 2025, indicating it was pre-scheduled. Following this sale, Wilkes directly holds 16,431 shares of National Vision common stock.

Insider Trade Summary 10b5-1

Net Seller: 35,000 shares ($928,900)

Net Sell 1 txn

Insider Wilkes Alexander

Role Chief Executive Officer

Sold 35,000 shs ($929K)

Type	Security	Shares	Price	Value
Sale	Common Stock	35,000	$26.54	$929K

Holdings After Transaction: Common Stock — 16,431 shares (Direct)

Footnotes (1)

1. This sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 5, 2025. Price represents the weighted average sales price. The shares were sold in multiple transactions as prices ranging from $26.21 to $26.91. Upon request by the SEC staff, the issuer or security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkes Alexander

(Last) (First) (Middle)

C/O NATIONAL VISION HOLDINGS, INC.

2435 COMMERCE AVENUE, BLDG 2200

(Street)

DULUTH GA 30096

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
National Vision Holdings, Inc. [ EYE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		S		35,000(1)	D	$26.54(2)	16,431	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 5, 2025.

2. Price represents the weighted average sales price. The shares were sold in multiple transactions as prices ranging from $26.21 to $26.91. Upon request by the SEC staff, the issuer or security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Jared Brandman, as Attorney-in-Fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did National Vision (EYE) report for its CEO?

National Vision’s CEO Alexander Wilkes reported selling 35,000 shares of common stock. The open-market sale occurred on March 11, 2026 and is disclosed in a Form 4 insider filing for National Vision Holdings, Inc. (EYE).

At what prices did the National Vision (EYE) CEO sell shares?

The CEO’s sale used a weighted average price of $26.54 per share. According to the filing, the 35,000 shares were sold in multiple transactions at prices ranging from $26.21 to $26.91 per share.

How many National Vision (EYE) shares does the CEO hold after the sale?

After selling 35,000 shares, CEO Alexander Wilkes directly holds 16,431 shares of National Vision common stock. This post-transaction ownership figure is reported in the Form 4 as the total shares beneficially owned following the transaction.

Was the National Vision (EYE) CEO’s share sale under a 10b5-1 plan?

Yes. The filing states the sale was executed under a Rule 10b5-1 trading plan. This plan was established by CEO Alexander Wilkes on December 5, 2025, indicating the sale was pre-scheduled rather than a discretionary, spur-of-the-moment trade.

What type of transaction did the National Vision (EYE) Form 4 disclose?

The Form 4 discloses an open-market sale of common stock by the CEO. It is coded as a sale transaction (“S”) for 35,000 shares, with details on pricing, date, and remaining ownership after the sale.